SecBot SecBot
Insider Cluster (2 insiders) ·Filed Sep 10, 2026

RXRX

RECURSION PHARMACEUTICALS, INC.
NEUTRAL
Impact 2/10
Horizondays Processed1mo ago
Insider cluster: 2 insiders, $179K total
Actionable Insight • Neutral

The insider sales are too small relative to market cap to warrant a bearish read. Monitor for any material corporate events (earnings, pipeline data, or financing) that could explain the timing, but on its own this cluster is noise.

DirectionNeutral
Confidencehigh
Horizondays
Latest settled — T+20d
RXRX ▲ +36.25% at T+20d
NEUTRAL call +36.25% · α vs SPY +34.38% · entry $3.20 → $4.36
Next anchor: T+60d in 5w
Latest observation: T+30 +27.14% FF3 residual α
Entry = T+0 close
Sep 10, 2026
via day close
T+1d
+6.56%
call +6.56% · α +7.01%
$3.41
settled 7w ago
T+5d
+19.69%
call +19.69% · α +20.03%
$3.83
settled 6w ago
T+20d
+36.25%
call +36.25% · α +34.38%
$4.36
settled 19d ago
T+60d
Pending
in 5w

Price Chart

Loading chart...

Executive Summary

CEO Najat Khan and Director Blake Borgeson sold a combined $179K in open-market RXRX shares over a one-week window. The CEO's sale is the first open-market sale by the top executive in the cluster, and the total value is only ~0.01% of market cap — trivial relative to company size. No 10b5-1 pattern is evident, but the dollar amount is too small to carry a bearish signal on its own. This is a routine, low-conviction cluster that does not change the fundamental outlook.

Key Financial Metrics

Direction
selling
Total Value
$179.0K
Insiders
2

Key Facts

  • CEO Khan Najat sold 22,408 shares at $3.52 for $79K on 2026-09-08
  • Director Blake Borgeson sold 30,000 shares at $3.34 for $100K on 2026-09-01
  • Total cluster value of $179K represents ~0.01% of RXRX's $1.7B market cap
  • Both sales were open-market (code S) — no 10b5-1 plan noted
  • No insider purchases in the cluster; net direction is selling

Financial Impact

Total insider sales of $179K, or ~0.01% of market cap — immaterial

insider_ownership

Risk Factors

  • CEO selling for the first time in the cluster could indicate personal diversification, but the small size limits informational content
  • No insider buying to offset the selling — a one-sided cluster, even if small

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
62% bullish (13 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-RXRX-1789077697879
21 reports for RXRX
Performance horizon
50% Hit rate @ T+5 2 of 4 directional calls Went positive at some point 2 of 4 best @ T+1▲ +16.71%Oct 15, 2026
Filters
Rows
Reports for RXRX — sortable, filterable
TypeNow
Oct 15, 2026
11d ago
424B5
BEARISH ★ 6/10
$3.47 $3.58▼ −3.32%▼ −3.23%$4.11 (−18.61%)
Oct 15, 2026
12d ago
8-K
MIXED ★ 6/10
$4.16 $3.58▼ −13.94%▼ −12.93%$4.11 (−1.20%)
Oct 15, 2026
12d ago
Press Release
MIXED ★ 5/10
$4.16 $3.58▼ −13.94%▼ −12.93%$4.11 (−1.20%)
Oct 15, 2026
12d ago
Press Release
BEARISH ★ 6/10
$4.16 $3.58▲ +13.94%▲ +12.93%$4.11 (+1.20%)
Oct 15, 2026
12d ago
Press Release
MIXED ★ 6/10
$4.16 $3.58▼ −13.94%▼ −12.93%$4.11 (−1.20%)
Oct 15, 2026
12d ago
424B5
BEARISH ★ 6/10
$4.16 $3.58▲ +13.94%▲ +12.93%$4.11 (+1.20%)
Oct 6, 2026
21d ago
144
NEUTRAL ★ 2/10
$4.63 $3.84▼ −17.17%▼ −17.03%$4.11 (−11.23%)
Oct 6, 2026
21d ago
144
NEUTRAL ★ 3/10
$4.63 $3.84▼ −17.17%▼ −17.03%$4.11 (−11.23%)
Sep 21, 2026
5w ago
8-K
MIXED ★ 5/10
$3.97 $3.70▼ −6.80%▼ −5.78%$4.11 (+3.53%)
Sep 10, 2026
6w ago
Insider Cluster
NEUTRAL ★ 2/10
$3.20 $3.83▲ +19.69%▲ +20.03%$4.11 (+28.44%)
Showing 10 of 21

US Market Status

Market Open — Closes in 2h 29m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 10, 2026